Overview
Marieke Van Der Linden practices practicing medicine in Nijmegen, Netherlands.
Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL) and Leukemia.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marieke H. Van Der Linden
Is Marieke H. Van Der Linden a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Marieke H. Van Der Linden is classified as an Experienced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marieke H. Van Der Linden participate in research or clinical trials?
Yes. Marieke H. Van Der Linden has published 10 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Marieke H. Van Der Linden's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Van Der Linden isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukemiaMs. Van Der Linden isExperienced. Learn about Leukemia.